½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1596194

¼¼°èÀÇ ¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Remote Cardiac Monitoring Devices Market by Devices Type (Cardiac Output Monitoring Devices, ECG Devices, Event Monitors), End User (Clinics & Cardiac Centers, Homecare & Hospitals) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 188 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ±â±â(Remote Cardiac Monitoring Devices) ½ÃÀåÀº 2023³â¿¡ 12¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 13¾ï 9,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, CAGR 16.24%·Î ¼ºÀåÇϸç 2030³â¿¡´Â 34¾ï 5,000¸¸ ´Þ·¯ ¿¹»óµË´Ï´Ù.

¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ±â±â´Â ÀçÅà ġ·á, º´¿ø, ¿Ü·¡ ȯÀÚ ½Ã¼³ µî ´Ù¾çÇÑ È¯°æ¿¡¼­ ȯÀÚÀÇ ½ÉÀå °Ç°­ µ¥ÀÌÅ͸¦ Áö¼ÓÀûÀ¸·Î Æò°¡ÇÏ°í Àü¼ÛÇϵµ·Ï ¼³°èµÈ ±¤¹üÀ§ÇÑ ÀÇ·á ±â¼úÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â±â´Â ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÏ°í ȯÀÚ °á°ú¸¦ °³¼±ÇÏ°í º´¿ø ¹æ¹®À» ÃÖ¼ÒÈ­ÇÏ´Â Àû½Ã¿¡ ºñ¿ë È¿À²ÀûÀÎ ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÌ ÇÊ¿äÇÏ´Ù´Â Á¡À» °í·ÁÇÒ ¶§ ÇÊ¿äÇÕ´Ï´Ù. ºÎÁ¤¸Æ °¨Áö, ½ÉºÎÀü °ü¸® ¹× ¼ö¼ú ÈÄ ¸ð´ÏÅ͸µ¿¡ ÀÏ»óÀûÀ¸·Î Àû¿ëµÇ¸ç ¿ø°Ý ÃøÁ¤ ±â±âºÎÅÍ È¦ÅÍ ¸ð´ÏÅÍ ¹× ½º¸¶Æ®¿öÄ¡¿Í °°Àº ¿þ¾î·¯ºí ½Ã½ºÅÛ¿¡ À̸£±â±îÁö ±¤¹üÀ§ÇÑ ÃÖÁ¾ »ç¿ë ½ºÆåÆ®·³À» Á¦°øÇÕ´Ï´Ù. Àü ¼¼°è Àα¸ °í·ÉÈ­, ÀÇ·á ºñ¿ë »ó½Â, µðÁöÅÐ °Ç°­ »ýÅ°è¿Í ¿øÈ°ÇÏ°Ô ÅëÇյǴ IoT ¹× AI ±â¼úÀÇ Ã¤Åà Áõ°¡·Î ½ÃÀåÀÌ È°±â¸¦ ¶ì°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ¿¬µµ(2023³â) 12¾ï ´Þ·¯
ÃßÁ¤¿¬µµ(2024³â) 13¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø¿¬µµ(2030³â) 34¾ï 5,000¸¸ ´Þ·¯
CAGR(%) 16.24%

ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î´Â ¼¾¼­ ±â¼ú°ú ¹«¼± º¯¼Ó±âÀÇ ±â¼ú Áøº¸, ȯÀÚ Áß½ÉÀÇ °Ç°­ °ü¸® Á߽à Áõ°¡, À¯¸®ÇÑ »óȯ Á¤Ã¥ µîÀÌ ÀÖ½À´Ï´Ù. Á¾ÇÕÀûÀÎ °Ç°­ ÁöÇ¥¸¦ Á¦°øÇÏ´Â ¿þ¾î·¯ºí ±â±â¸¦ äÅÃÇÏ´Â ¼ÒºñÀÚ°¡ ´Ã¾î³ª°í ÀÖÀ¸¸ç, ¼ºÀå °¡´É¼ºÀÌ ÇöÀúÇÕ´Ï´Ù. COVID-19 ÀÌÈÄ ¿ø°Ý ÀÇ·á µµÀÔÀÇ ±ÞÁõÀº ÀÌ·¯ÇÑ ±â±âÀÇ À¯¿ë¼ºÀ» ´õ¿í °­È­ÇÕ´Ï´Ù. ¿¹Ãø ºÐ¼®°ú ȯÀÚ °èÃþÈ­ µµ±¸¸¦ À§ÇØ AI¿Í ¸Ó½Å·¯´×À» È°¿ëÇϰųª µ¥ÀÌÅÍ Åë½ÅÀÇ ½Å·Ú¼ºÀ» ³ôÀ̱â À§ÇØ Åë½Å»ç¿Í Á¦ÈÞÇÒ ±âȸ°¡ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. ±×·³¿¡µµ ºÒ±¸ÇÏ°í µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á, ±ÔÁ¦»óÀÇ Àå¾Ö¹°, °ß°íÇÑ »çÀ̹ö º¸¾È ´ëÃ¥ÀÇ Çʿ伺 µî °úÁ¦´Â ½ÃÀåÀÇ ±Þ¼ÓÇÑ ÁøÀüÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ Ã·´Ü ÀåºñÀÇ °í°¡ÀÇ ºñ¿ë°ú º¹ÀâÇÑ º¸Çè »óȯµµ Å« À庮ÀÌ µÇ°í ÀÖ½À´Ï´Ù.

Çõ½ÅÀº ¹èÅ͸® ¼ö¸íÀÌ Çâ»óµÇ°í µ¥ÀÌÅÍ Á¤È®µµ°¡ Çâ»óµÇ°í »ç¿ëÇϱ⠽±°í ½Å·Ú¼ºÀÌ ³ô°í Àú·ÅÇÑ ¸ð´ÏÅ͸µ ±â±â °³¹ß¿¡ ÁßÁ¡À» µÎ¾î¾ß ÇÕ´Ï´Ù. ÀÏ»óÀûÀÎ ¿þ¾î·¯ºí°ú ¿øÈ°ÇÏ°Ô °áÇÕÇÏ´Â ºñħ½ÀÀû ±â¼ú ÅëÇÕ¿¡ ´ëÇÑ Á¶»ç´Â Å« ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ¼­·Î ´Ù¸¥ °Ç°­ °ü¸® Ç÷§Æû °£ÀÇ ¾ÈÀüÇÑ µ¥ÀÌÅÍ °øÀ¯ ¹× »óÈ£ ¿î¿ë¼ºÀ» À§ÇØ ºí·ÏüÀÎÀ» Ž±¸ÇÏ¸é µ¥ÀÌÅÍ º¸¾È ¹®Á¦¸¦ ÇØ°áÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå »óȲÀº ¿ªµ¿ÀûÀ̸ç Çõ½Å°ú Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ¿ì¼±½ÃÇÏ°í ±â¼úÀû Á¤±³ÇÔ°ú Á¢±Ù¼º°ú ȯÀÚ Âü¿©ÀÇ ±ÕÇüÀ» ¸ÂÃß´Â ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â ±â¾÷¿¡°Ô´Â Å« °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ÁÖ¿ä ÀλçÀÌÆ® °ø°³

¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯È­¸¦ °Þ°í ÀÖ½À´Ï´Ù. ¼¼·ÃµÇ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ¾ò´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆľÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ´õ ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÉÇ÷°üÁúȯÀÇ À¯º´·ü Áõ°¡
    • Çõ½ÅÀûÀÎ ÈÞ´ë ±â±âÀÇ Ã¤ÅÃ
    • ¸¶ÀÌÅ©·Î ÀÏ·ºÆ®·Î´Ð½º¿Í µ¥ÀÌÅÍ Àü¼Û ±â¼úÀÇ Çõ½ÅÀÇ Ã¤ÅÃ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • »çÀ̹ö º¸¾È Ãë¾àÁ¡¿¡ ´ëÇÑ À§Çè
    • Á¦Ç° ¸®ÄÝ
  • ½ÃÀå ±âȸ
    • ÅõÀÚ¿Í ÀÚ±Ý Áõ°¡
    • COVID-19¿¡ ÀÇÇÑ ¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ±â±â¿¡ÀÇ °æ»ç
  • ½ÃÀå °úÁ¦
    • ³óÃÌ¿¡¼­ ÀÎÁöµµ¡¤º¸±ÞµµÀÇ ³·À½, ÀüÁö ¼ö¸í µî ±â¼úÀû ¹®Á¦

Porter's Five Forces : ¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÇ ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇϴµ¥ µµ¿òÀÌ µË´Ï´Ù. ÇÇÇÒ ¼ö ÀÖÀ¸¸ç ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸Àå ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆľÇ

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡, °æÁ¦, »çȸ, ±â¼ú, ¹ý·ü ¹× ȯ°æ ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ¿© ¼±Á¦ÀûÀÌ°í ¹Ì·¡ ÁöÇâÀûÀÎ ÀÇ»ç °áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå °æÀï ±¸µµ ÆľÇ

¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü µîÀÇ ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï ¿ìÀ§¸¦ ÆľÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀå ÁýÁßµµ, ¼¼ºÐÈ­, ÅëÇÕ Ãß¼¼¸¦ °­Á¶ÇÏ¿© º¥´õ°¡ °æÀïÀÌ Ä¡¿­ÇØÁö´Â ȯ°æ¿¡¼­ ÀÔÁö¸¦ °­È­ÇÏ´Â Àü·«Àû °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î º¥´õ¸¦ Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. 4°³ÀÇ »çºÐ¸éÀº °ø±Þ¾÷ü¸¦ ¸íÈ®ÇÏ°í Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© »ç¿ëÀÚ°¡ Àü·«Àû ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æ ã±â

¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ±Û·Î¹ú ½ÃÀå¿¡¼­ ÀÔÁö °­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ È°¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖ´Â ½Ã½ºÅÛÀ» ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆľÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D È°µ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇÏ°í ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ ¹× ±ÔÁ¦ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø ¹× Àü·«Àû ±âȸ´Â?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ½ÉÇ÷°ü ÁúȯÀÇ ÀÌȯÀ² Áõ°¡
      • Çõ½ÅÀûÀÌ°í ÈÞ´ë¿ë ±â±âÀÇ Ã¤ÅÃ
      • ¸¶ÀÌÅ©·Î ÀÏ·ºÆ®·Î´Ð½º¿Í µ¥ÀÌÅÍ Æ®·£½º¹Ì¼Ç ±â¼úÀÇ Çõ½ÅÀ» äÅÃ
    • ¾ïÁ¦¿äÀÎ
      • »çÀ̹ö º¸¾È Ãë¾àÁ¡°ú °ü·ÃµÈ À§Çè
      • Á¦Ç° ¸®ÄÝ
    • ±âȸ
      • ÅõÀÚ¿Í ÀÚ±Ý Áõ°¡
      • COVID-19¿¡ ÀÇÇÑ ¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ±â±â¿¡ ´ëÇÑ °æÇâ
    • °úÁ¦
      • Áö¹æ¿¡¼­ ÀÎÁöµµ¿Í º¸±ÞÀÌ ÇÑÁ¤µÇ¾î ÀÖ¾î, ¹èÅ͸® ¼ö¸í µî ±â¼úÀûÀÎ ¹®Á¦°¡ Á¸Àç
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦Àû
    • »çȸÀû
    • ±â¼úÀû
    • ¹ýÀû
    • ȯ°æÀû

Á¦6Àå ¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : ±â±â À¯Çüº°

  • ½É¹ÚÃâ·® ¸ð´ÏÅ͸µ ±â±â
  • ECG ±â±â
    • ȦÅÍ ¸ð´ÏÅÍ
    • È޽Ľà ½ÉÀüµµ ±â±â
    • ½ºÆ®·¹½º ½ÉÀüµµ ±â±â
  • À̺¥Æ® ¸ð´ÏÅÍ
  • À̽ÄÇü ·çÇÁ ·¹ÄÚ´õ
  • ¸ð¹ÙÀÏ ½ÉÀå ¿ø°Ý ÃøÁ¤ ±â±â

Á¦7Àå ¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • Ŭ¸®´Ð°ú ½ÉÀå¼¾ÅÍ
  • ÀçÅà Äɾî¿Í º´¿ø

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ ¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå

  • ¾Æ¸£ÇîƼ³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ ¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍÅ°
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Ãßõ

±â¾÷ ¸ñ·Ï

  • Abbott Laboratories
  • ACS Diagnostics
  • Asahi Kasei Corporation
  • BIOTRONIK SE&Co KG
  • Boston Scientific Corporation
  • BPL Medical Technologies
  • GE Healthcare
  • Hill-Rom Holdings, Inc.
  • Koninklijke Philips NV
  • Lepu Medical Technology(Beijing) Co.,Ltd.
  • Medtronic Plc
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Schiller Americas, inc.
  • Vector Remote Care LLC
LYJ

The Remote Cardiac Monitoring Devices Market was valued at USD 1.20 billion in 2023, expected to reach USD 1.39 billion in 2024, and is projected to grow at a CAGR of 16.24%, to USD 3.45 billion by 2030.

Remote cardiac monitoring devices encompass a wide array of medical technologies designed to continuously assess and transmit cardiac health data from patients in diverse settings, including homecare, hospitals, and outpatient facilities. These devices are necessary given the increasing prevalence of cardiovascular diseases and the need for timely, cost-effective monitoring solutions that enhance patient outcomes and minimize hospital visits. They are routinely applied for arrhythmia detection, heart failure management, and post-surgical monitoring, serving a broad end-use spectrum from telemetry devices to wearable systems like Holter monitors and smartwatches. The market is buoyed by an aging global population, rising healthcare costs, and the growing adoption of IoT and AI technologies that integrate seamlessly with digital health ecosystems.

KEY MARKET STATISTICS
Base Year [2023] USD 1.20 billion
Estimated Year [2024] USD 1.39 billion
Forecast Year [2030] USD 3.45 billion
CAGR (%) 16.24%

Key growth drivers include technological advancements in sensor technology and wireless transmission, the growing emphasis on patient-centric healthcare, and favorable reimbursement policies. There is a notable potential for growth as consumers increasingly adopt wearable devices offering comprehensive health metrics. A surge in telehealth adoption post-COVID-19 further strengthens the utility of these devices. Opportunities demand leveraging AI and machine learning for predictive analytics and patient stratification tools, and partnerships with telecommunication companies to enhance data transmission reliability. Nonetheless, challenges such as data privacy concerns, regulatory hurdles, and the need for robust cybersecurity measures may hinder rapid market advancement. The high cost of advanced devices and reimbursement complexities also pose substantial barriers.

Innovation should focus on developing more user-friendly, reliable, and affordable monitoring devices with enhanced battery lives and improved data accuracy. Research into integrating non-invasive technology that seamlessly combines with everyday wearables holds significant promise. Exploring blockchain for secure data sharing and interoperability among different healthcare platforms could resolve data security issues. The remote cardiac monitoring devices market is dynamic, with significant potential for firms that prioritize innovation and strategic partnerships, contributing solutions that balance technological sophistication with accessibility and patient engagement, thus catering to a digitally transforming healthcare landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Remote Cardiac Monitoring Devices Market

The Remote Cardiac Monitoring Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased prevalence of cardiovascular disease
    • Adoption of innovative and portable devices
    • Adopting innovations in microelectronics and data transmission technology
  • Market Restraints
    • Risk related to cybersecurity vulnerabilities
    • Product recall
  • Market Opportunities
    • Increasing investments and funds
    • Inclination towards remote cardiac monitoring devices due to COVID-19
  • Market Challenges
    • Limited awareness & adoption in rural areas and technical issues such as battery life

Porter's Five Forces: A Strategic Tool for Navigating the Remote Cardiac Monitoring Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Remote Cardiac Monitoring Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Remote Cardiac Monitoring Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Remote Cardiac Monitoring Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Remote Cardiac Monitoring Devices Market

A detailed market share analysis in the Remote Cardiac Monitoring Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Remote Cardiac Monitoring Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Remote Cardiac Monitoring Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Remote Cardiac Monitoring Devices Market

A strategic analysis of the Remote Cardiac Monitoring Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Remote Cardiac Monitoring Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics, Asahi Kasei Corporation, BIOTRONIK SE & Co KG, Boston Scientific Corporation, BPL Medical Technologies, GE Healthcare, Hill-Rom Holdings, Inc., Koninklijke Philips N.V., Lepu Medical Technology(Beijing)Co.,Ltd., Medtronic Plc, MicroPort Scientific Corporation, Nihon Kohden Corporation, Schiller Americas, inc., and Vector Remote Care LLC.

Market Segmentation & Coverage

This research report categorizes the Remote Cardiac Monitoring Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Devices Type, market is studied across Cardiac Output Monitoring Devices, ECG Devices, Event Monitors, Implantable Loop Recorders, and Mobile Cardiac Telemetry Devices. The ECG Devices is further studied across Holter Monitors, Resting ECG Devices, and Stress ECG Devices.
  • Based on End User, market is studied across Clinics & Cardiac Centers and Homecare & Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased prevalence of cardiovascular disease
      • 5.1.1.2. Adoption of innovative and portable devices
      • 5.1.1.3. Adopting innovations in microelectronics and data transmission technology
    • 5.1.2. Restraints
      • 5.1.2.1. Risk related to cybersecurity vulnerabilities
      • 5.1.2.2. Product recall
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investments and funds
      • 5.1.3.2. Inclination towards remote cardiac monitoring devices due to COVID-19
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness & adoption in rural areas and technical issues such as battery life
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Remote Cardiac Monitoring Devices Market, by Devices Type

  • 6.1. Introduction
  • 6.2. Cardiac Output Monitoring Devices
  • 6.3. ECG Devices
    • 6.3.1. Holter Monitors
    • 6.3.2. Resting ECG Devices
    • 6.3.3. Stress ECG Devices
  • 6.4. Event Monitors
  • 6.5. Implantable Loop Recorders
  • 6.6. Mobile Cardiac Telemetry Devices

7. Remote Cardiac Monitoring Devices Market, by End User

  • 7.1. Introduction
  • 7.2. Clinics & Cardiac Centers
  • 7.3. Homecare & Hospitals

8. Americas Remote Cardiac Monitoring Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Remote Cardiac Monitoring Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Remote Cardiac Monitoring Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ACS Diagnostics
  • 3. Asahi Kasei Corporation
  • 4. BIOTRONIK SE & Co KG
  • 5. Boston Scientific Corporation
  • 6. BPL Medical Technologies
  • 7. GE Healthcare
  • 8. Hill-Rom Holdings, Inc.
  • 9. Koninklijke Philips N.V.
  • 10. Lepu Medical Technology(Beijing)Co.,Ltd.
  • 11. Medtronic Plc
  • 12. MicroPort Scientific Corporation
  • 13. Nihon Kohden Corporation
  • 14. Schiller Americas, inc.
  • 15. Vector Remote Care LLC
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦